234 related articles for article (PubMed ID: 29690750)
1. Cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway.
Ma J; Song X; Xu X; Mou Y
Cancer Res Treat; 2019 Jan; 51(1):194-210. PubMed ID: 29690750
[TBL] [Abstract][Full Text] [Related]
2. Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating MGMT expression via IL‑6/JAK/STAT3‑mediated PD‑L1 activity.
Feng X; Xue F; He G; Ni Q; Huang S
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278452
[TBL] [Abstract][Full Text] [Related]
3. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer.
Ham IH; Oh HJ; Jin H; Bae CA; Jeon SM; Choi KS; Son SY; Han SU; Brekken RA; Lee D; Hur H
Mol Cancer; 2019 Mar; 18(1):68. PubMed ID: 30927911
[TBL] [Abstract][Full Text] [Related]
4. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
[TBL] [Abstract][Full Text] [Related]
6. Anti-Gastric Cancer Effect of Purified
Xu Y; Xu W; Lu Z; Cheung MH; Lin M; Liang C; Lou J; Chen Y
Nutr Cancer; 2022; 74(5):1780-1791. PubMed ID: 34601984
[TBL] [Abstract][Full Text] [Related]
7. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
8. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.
Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination.
Yasuda T; Koiwa M; Yonemura A; Miyake K; Kariya R; Kubota S; Yokomizo-Nakano T; Yasuda-Yoshihara N; Uchihara T; Itoyama R; Bu L; Fu L; Arima K; Izumi D; Iwagami S; Eto K; Iwatsuki M; Baba Y; Yoshida N; Ohguchi H; Okada S; Matsusaki K; Sashida G; Takahashi A; Tan P; Baba H; Ishimoto T
Cell Rep; 2021 Feb; 34(8):108779. PubMed ID: 33626356
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of IL-11 promotes premalignant gastric epithelial hyperplasia in isolation from germline gp130-JAK-STAT driver mutations.
Buzzelli JN; O'Connor L; Scurr M; Chung Nien Chin S; Catubig A; Ng GZ; Oshima M; Oshima H; Giraud AS; Sutton P; Judd LM; Menheniott TR
Am J Physiol Gastrointest Liver Physiol; 2019 Feb; 316(2):G251-G262. PubMed ID: 30520693
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1.
Wang X; Che X; Liu C; Fan Y; Bai M; Hou K; Shi X; Zhang X; Liu B; Zheng C; Liu Y; Qu X
Exp Cell Res; 2018 Jul; 368(2):184-193. PubMed ID: 29709516
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway.
Ham IH; Wang L; Lee D; Woo J; Kim TH; Jeong HY; Oh HJ; Choi KS; Kim TM; Hur H
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35621145
[TBL] [Abstract][Full Text] [Related]
13. Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation.
Kim SM; Kwon OJ; Hong YK; Kim JH; Solca F; Ha SJ; Soo RA; Christensen JG; Lee JH; Cho BC
Mol Cancer Ther; 2012 Oct; 11(10):2254-64. PubMed ID: 22891040
[TBL] [Abstract][Full Text] [Related]
14. Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway.
Bei Y; Chen X; Xu Q; Lv J; Hu J; Yang S
Drug Dev Res; 2022 Apr; 83(2):379-388. PubMed ID: 34405891
[TBL] [Abstract][Full Text] [Related]
15. Gastric Cancer Cell-Derived Kynurenines Hyperactive Regulatory T Cells to Promote Chemoresistance via the
Wu D; Wang Z
DNA Cell Biol; 2022 Apr; 41(4):447-455. PubMed ID: 35353612
[TBL] [Abstract][Full Text] [Related]
16. Stromal Lkb1 deficiency leads to gastrointestinal tumorigenesis involving the IL-11-JAK/STAT3 pathway.
Ollila S; Domènech-Moreno E; Laajanen K; Wong IP; Tripathi S; Pentinmikko N; Gao Y; Yan Y; Niemelä EH; Wang TC; Viollet B; Leone G; Katajisto P; Vaahtomeri K; Mäkelä TP
J Clin Invest; 2018 Jan; 128(1):402-414. PubMed ID: 29202476
[TBL] [Abstract][Full Text] [Related]
17. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
[TBL] [Abstract][Full Text] [Related]
18. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo.
Judd LM; Menheniott TR; Ling H; Jackson CB; Howlett M; Kalantzis A; Priebe W; Giraud AS
PLoS One; 2014; 9(5):e95993. PubMed ID: 24804649
[TBL] [Abstract][Full Text] [Related]
20. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
